139 related articles for article (PubMed ID: 27913747)
1. Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer.
Chen XQ; Zheng LX; Li ZY; Lin TY
J Int Med Res; 2017 Feb; 45(1):51-58. PubMed ID: 27913747
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
[TBL] [Abstract][Full Text] [Related]
7. Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.
Wu H; Qi XW; Yan GN; Zhang QB; Xu C; Bian XW
PLoS One; 2014; 9(6):e100168. PubMed ID: 24940615
[TBL] [Abstract][Full Text] [Related]
8. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
11. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
13. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
[TBL] [Abstract][Full Text] [Related]
17. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
18. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
Zhang TM; Zhang J; Zhou DJ; Wang CL
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
[No Abstract] [Full Text] [Related]
19. Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer.
Lai JC; Cheng YW; Chiou HL; Wu MF; Chen CY; Lee H
Int J Cancer; 2005 Dec; 117(6):974-80. PubMed ID: 15986439
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer.
Jin T; Jin J; Li X; Zhang S; Choi YH; Piao Y; Shen X; Lin Z
BMC Cancer; 2014 Mar; 14():191. PubMed ID: 24629131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
